Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock
CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.75−0.26 (-8.80%)
Close on Nov 18, 2026Market cap $53.09MP/E –Yield –
Corbus Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Corbus Pharmaceuticals's price to book ratio was 0.7× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.3× to 375.6×, with a median of 1.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.7× | −0.4 |
| 2025 | Dec 31, 2025 | 1.1× | +0.2 |
| 2024 | Dec 31, 2024 | 1.0× | −84.7 |
| 2023 | Dec 29, 2023 | 85.6× | +85.3 |
| 2022 | Dec 30, 2022 | 0.3× | −0.7 |
| 2021 | Dec 31, 2021 | 1.0× | −2.5 |
| 2020 | Dec 31, 2020 | 3.5× | −8.4 |
| 2019 | Dec 31, 2019 | 11.9× | +4.1 |
| 2018 | Dec 31, 2018 | 7.8× | −3.4 |
| 2017 | Dec 29, 2017 | 11.2× | −16.8 |
| 2016 | Dec 30, 2016 | 27.9× | +22.4 |
| 2015 | Dec 31, 2015 | 5.6× | −5.4 |
| 2014 | Dec 31, 2014 | 11.0× | – |
See a number that looks wrong?